{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:34:24Z","timestamp":1761561264795},"reference-count":26,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"DOI":"10.1210\/en.2008-0724","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T21:33:26Z","timestamp":1216762406000},"page":"3761-3763","source":"Crossref","is-referenced-by-count":7,"title":["Stroke Therapy: Is Spironolactone the Holy Grail?"],"prefix":"10.1210","volume":"149","author":[{"given":"Anne M.","family":"Dorrance","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology Michigan State University East Lansing, Michigan 48824"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"2020071612165504500_R1","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.STR.0000229883.72010.e4","article-title":"Potential new risk factors for ischemic stroke: what is their potential?","volume":"37","author":"Hankey","year":"2006","journal-title":"Stroke"},{"key":"2020071612165504500_R2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.RVI.0000108687.75691.0C","article-title":"Pathophysiology of focal cerebral ischemia: a therapeutic perspective","volume":"15","author":"Smith","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"2020071612165504500_R3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.STR.0000065198.80347.C5","article-title":"Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.","volume":"34","author":"Heuschmann","year":"2003","journal-title":"Stroke"},{"key":"2020071612165504500_R4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2004-861497","article-title":"Cerebrovascular risk factors and clinical classification of strokes.","volume":"4","author":"Pinto","year":"2004","journal-title":"Semin Vasc Med"},{"key":"2020071612165504500_R5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.21127","article-title":"Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.","volume":"61","author":"Savitz","year":"2007","journal-title":"Ann Neurol"},{"key":"2020071612165504500_R6","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/STROKEAHA.107.504415","article-title":"A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke.","volume":"39","author":"Savitz","year":"2008","journal-title":"Stroke"},{"key":"2020071612165504500_R7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000118039","article-title":"Improving outcome after stroke: overcoming the translational roadblock.","volume":"25","author":"Endres","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"2020071612165504500_R8","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1210\/en.2007-1770","article-title":"The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia.","volume":"149","author":"Oyamada","year":"2008","journal-title":"Endocrinology"},{"key":"2020071612165504500_R9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases.","volume":"107","author":"Conn","year":"1964","journal-title":"Am J Surg"},{"key":"2020071612165504500_R10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan.","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"2020071612165504500_R11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues.","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612165504500_R12","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","article-title":"Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats","volume":"281","author":"Dorrance","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020071612165504500_R13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mvr.2006.12.001","article-title":"Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.","volume":"73","author":"Rigsby","year":"2007","journal-title":"Microvasc Res"},{"key":"2020071612165504500_R14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature.","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"2020071612165504500_R15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000093212","article-title":"Blood pressure management in acute stroke: a long-standing debate.","volume":"55","author":"Spengos","year":"2006","journal-title":"Eur Neurol"},{"key":"2020071612165504500_R16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0006-8993(02)03042-1","article-title":"The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat.","volume":"947","author":"Fischer","year":"2002","journal-title":"Brain Res"},{"key":"2020071612165504500_R17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.2911756","article-title":"Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy.","volume":"243","author":"Sloviter","year":"1989","journal-title":"Science"},{"key":"2020071612165504500_R18","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1111\/j.1460-9568.2004.03717.x","article-title":"The corticoid environment: a determining factor for neural progenitors\u2019 survival in the adult hippocampus.","volume":"20","author":"Wong","year":"2004","journal-title":"Eur J Neurosci"},{"key":"2020071612165504500_R19","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1097\/00001756-199809140-00031","article-title":"Mineralocorticoid receptors regulate bcl-2 and p53 mRNA expression in hippocampus.","volume":"9","author":"McCullers","year":"1998","journal-title":"Neuroreport"},{"key":"2020071612165504500_R20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1096\/fasebj.14.5.779","article-title":"Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate.","volume":"14","author":"Almeida","year":"2000","journal-title":"FASEB J"},{"key":"2020071612165504500_R21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1046\/j.1460-9568.2003.02587.x","article-title":"Mineralocorticoid receptor expression and increased survival following neuronal injury.","volume":"17","author":"Macleod","year":"2003","journal-title":"Eur J Neurosci"},{"key":"2020071612165504500_R22","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.jcbfm.9600457","article-title":"Deleterious effects of dihydrotestosterone on cerebral ischemic injury.","volume":"27","author":"Cheng","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"2020071612165504500_R23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/brain\/awm183","article-title":"Progesterone for the treatment of experimental brain injury; a systematic review.","volume":"131","author":"Gibson","year":"2008","journal-title":"Brain"},{"key":"2020071612165504500_R24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries.","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"key":"2020071612165504500_R25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox.","volume":"93","author":"Funder","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612165504500_R26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/8\/3761\/8997377\/endo3761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/8\/3761\/8997377\/endo3761.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T19:45:05Z","timestamp":1594928705000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/149\/8\/3761\/2455495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2008-0724","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,1]]}}}